Usefulness of patient's history and non-invasive electrocardiographic parameters in prediction of ajmaline test results in patients with suspected Brugada syndrome

Archives of Medical Science

Volumn 10, Issue 5, 2014, Pages 1-14

  Uzieblo Zyczkowska, Beata ^a   Gielerak, Grzegorz ^a   Michalkiewicz, Dariusz ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Ajmaline challenge; Brugada syndrome; Non invasive predictors

Indexed keywords

AJMALINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; BRUGADA SYNDROME; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECG ABNORMALITY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FAINTNESS; FAMILY HISTORY; FEMALE; HOLTER MONITORING; HUMAN; INTERVIEW; J POINT ELEVATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INVASIVE PROCEDURE; PHYSICAL EXAMINATION; PREDICTION; PREDICTIVE VALUE; PROVOCATION TEST; QRS COMPLEX; QRS DURATION; QT DISPERSION; QT INTERVAL; QT PEAK INTERVAL; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; T PEAK T END DISPERSION; T PEAK T END INTERVAL; T WAVE;

EID: 84908447342     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2013.36928     Document Type: Article

References (33)

1. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart J 1920; 7: 353-70.
2. Hodges M, Salerno D, Erlien D. Bazett's QT correlation reviewed. Evidence that a linear QT correction for heart is better. J Am Coll Cardiol 1983; 1: 694.
3. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada Syndrome. Report of the second consensus conference. Circulation 2005; 111: 659-70.
4. Wilde AM, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome. Consensus Report. Circulation 2002; 106: 2514-9.
5. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000; 101: 510-5.
6. Rolf S, Bruns HJ, Wichter T, et al. The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. Eur Heart J 2003; 24: 1104-12.
7. Gasparini M, Priori SG, Mantica M, et al. Flecainide test in Brugada syndrome: a reproducible but risky tool. Pacing Clin Electrophysiol 2003; 26: 338-41.
8. Chinushi M, Komura S, Izumi D, et al. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome. Pacing Clin Electrophysiol 2007; 30: 662-71.
9. Morita H, Morita ST, Nagase S, et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003; 42: 1624-31.
10. Wolpert C, Echternach C, Veltmann C, et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2005; 2: 254-60.
11. Shimizu W. The Brugada syndrome - an update. Intern Med 2005; 44: 1224-31.
12. Hong K, Brugada J, Oliva A, et al. Value of electro cardio -graphic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004; 110: 3023-7.
13. Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AA, Tan HL. Diagnostic value of flecainide testing in un-masking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 2006; 17: 857-64.
14. Padrini R, Piovan D, Javarnaro A, Cucchini F, Ferrari M. Pharmacokinetics and electrophysiological effects of intravenous ajmaline. Clin Pharmacokinet 1993; 25: 408-14.
15. Batchvarov VN, Givindan M, Camm AJ, Behr ER. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome. Heart Rhythm 2009; 6: 625-31.
16. Eckardt L. Gender differences in Brugada syndrome. J Cardiovasc Electrophysiol 2007; 18: 422-4.
17. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 2006; 29: 1130-59.
18. Veltmann Ch, Wolpert C, Sacher F, et al. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges. Europace 2009; 11: 1345-52.
19. Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wie -ling W, van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol 2006; 17: 1172-6.
20. Sarasin FP, Pruvot E, Louis-Simonet M, et al. Stepwise evaluation of syncope: a prospective population-based controlled study. Int J Cardiol 2008; 127: 103-11.
21. Brugada P, Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-6.
22. Ikeda T, Sakabe K, Sakata T, et al. Assessment of non-invasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol 2001; 37: 1628-34.
23. Atarashi H, Ogawa S. New ECG criteria for high-risk Brugada syndrome. Circ J 2003; 67: 8-10.
24. Miyasaka Y, Tsuji H, Yamada K, et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol 2001; 38: 771-4.
25. Hermida JS, Lemoine JL, Aoun FB, Jarry G, Rey JL, Quiret JC. Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol 2000; 86: 91-4.
26. Bozkurt A, Yas D, Seydaoglu G, Acartürk E. Frequency of Brugada-type ECG pattern (Brugada sign) in Southern Turkey. Int Heart J 2006; 47: 541-7.
27. Kamakura S, Ohe T, Nakazawa K, et al.; the Brugada Syndrome Investigators In Japan. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythmia Electrophysiol 2009; 2: 495-503.
28. Takagi M, Yokoyama Y, Aomuma K, Aihara N, Hiraoka M; the Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with Brugada syndrome: Multicenter study in Japan. J Cardiovasc Electrophysiol 2007; 18: 1244-51.
29. Matsuo K, Kurita T, Inagaki M, et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 1999; 20: 465-70.
30. Takigawa M, Noda T, Shimizu W, et al. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm 2008; 5: 1523-7.
31. Extramiana F, Seitz J, Maison-Blanche P, et al. Quantitative assessment of ST segment elevation in Brugada patients. Heart Rhythm 2006; 3: 1175-81.
32. Sarkozy A, Chierchia GB, Paparella G, et al. Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome. Circ Arrhythm Electrophysiol 2009; 2: 154-61.
33. Babai Bigi MA, Aslani A, Shahrzad S. aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome. Heart Rhythm 2007; 4: 1009-12.